RHYTHM PHARMACEUTICALS, INC. (RYTM) insider trading

By person

38 insiders · 351 transactions

31.1×

David P. Meeker holds 31.1 times base salary in stock. $25.17M of shares against $807.69K in salary for 2025.

Salary from the company's own proxy. The shares are what David P. Meeker last reported holding, valued at $105.19, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Todd Foley

Director

$1.70M (1)

$50.56M (47)

−$48.86M

909,258

1.32%

$95.64M

+122.9%

Hunter C Smith

Chief Financial Officer

—

$19.38M (51) scheduled

−$19.38M

114,024

0.1656%

$11.99M

—

Jennifer Kayden Lee

EVP, Head of North America

—

$16.91M (36) scheduled

−$16.91M

0.0000%

$0.00

−100.0%

Joseph Shulman

Chief Technical Officer

—

$15.73M (41) scheduled

−$15.73M

15,915

0.0231%

$1.67M

—

Baker Bros. Advisors LP entity

Former 10% owner

$15.05M (2)

—

+$15.05M

1,878,242

2.73%

$197.57M

—

Ra Capital Management, L.p. entity

Former 10% Owner

—

$13.40M (12)

−$13.40M

4,360,860

6.33%

$458.72M

−10.7%

Yann Mazabraud

EVP, Head of International

—

$12.84M (17) scheduled

−$12.84M

55,655

0.0808%

$5.85M

+168.4%

Pamela J. Cramer

Chief Human Resources Officer

—

$10.96M (32) scheduled

−$10.96M

29,376

0.0427%

$3.09M

+1,080%

David P Meeker

President and CEO

$626.71K (2)

$10.77M (11) scheduled

−$10.15M

239,258

0.3475%

$25.17M

+752.3%

M James Barrett

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

Peter J Barris

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

Forest Baskett

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

Patrick J Kerins

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

David M Mott

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

New Enterprise Associates 13 LP entity

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

Scott D Sandell

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

Ravi Viswanathan

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

James E Flynn

10% owner

$6.04M (2)

—

+$6.04M

468,505

0.6805%

$49.28M

—

Lynn A. Tetrault

Director

—

$5.40M (8) scheduled

−$5.40M

11,712

0.0170%

$1.23M

—

Jennifer L Good

Director

—

$4.27M (3) scheduled

−$4.27M

11,712

0.0170%

$1.23M

—

David W J McGirr

Director

—

$4.27M (2) scheduled

−$4.27M

11,712

0.0170%

$1.23M

—

der Ploeg Leonardus H.T. Van

Chief Scientific Officer

—

$2.73M (11) scheduled

−$2.73M

42,339

0.0615%

$4.45M

−34.2%

Keith Michael Gottesdiener

CEO & President

—

$2.48M (15)

−$2.48M

558,250

0.8108%

$58.72M

−0.3%

Mpm Bioventures V, L.p.

10% owner

$1.70M (1)

—

+$1.70M

2,696,392

3.92%

$283.63M

+9,078%

Christopher Paul German

Corporate Controller & CAO

—

$1.59M (9) scheduled

−$1.59M

0.0000%

$0.00

−100.0%

Nithya Desikan

Chief Commercial Officer

—

$1.55M (2) scheduled

−$1.55M

43,602

0.0633%

$4.59M

—

Orbimed Advisors LLC entity

10% owner

$6.04M (1)

$4.66M (4)

+$1.37M

2,750,079

3.99%

$289.28M

—

Alastair Garfield

Chief Scientific Officer

—

$998.19K (6) scheduled

−$998.19K

2,295

0.0033%

$241.41K

—

Pfizer Inc entity

10% owner

$680.00K (1)

—

+$680.00K

1,427,639

2.07%

$150.17M

—

Ipsen, S.A.

10% owner

$340.00K (1)

—

+$340.00K

833,099

1.21%

$87.63M

+39.0%

William T. Roberts

Chief Accounting Officer

—

$53.87K (3) scheduled

−$53.87K

7,872

0.0114%

$828.06K

+128.0%

Third Rock Ventures LP entity

10% owner

—

2,981,437

4.33%

$313.62M

+16,814%

Hadley Harbor Master Investors (Cayman) L.P.

10% owner

—

545,256

0.7919%

$57.36M

—

Edward T Mathers

Director

—

21,168

0.0307%

$2.23M

—

Stuart A Arbuckle

Director

—

11,712

0.0170%

$1.23M

—

Christophe Jean

Director

—

11,712

0.0170%

$1.23M

—

Camille L Bedrosian

Director

—

7,000

0.0102%

$736.33K

—

Neil Exter

Director

—

0.0000%

$0.00

—

RHYTHM PHARMACEUTICALS, INC.

What the insiders did Net buying

By person